News
November 2009
During the Pre-IDE meeting with FDA representatives 510K regulatory path was confirmed.
September 2009
The company was presented at ESVS (European Vascular Surgery Society) Exhibition in Oslo, Norway.
August 2009
HDH launched a post-marketing trial in Augusta Hospital, Dusseldorf, Germany. Up to 10 patients suffering from Abdominal Aortic Aneurysms and Aorto-Il
June 2009
HDH Medical received the CE approval for open and Laparoscopic treatment of arterial aneurysms, occlusions and traumas.
